14
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Increased Rate of Survival in Streptococcus pneumoniae-Infected Rats Treated with the New Immunomodulator Pidotimod

, , , , , , , & show all
Pages 821-823 | Published online: 08 Jul 2009

References

  • Bruyn G AW, Zegers B JM, van Furth R. Mechanisms of host defense against infection with Streptococcus pneumoniae. Clin Infect Dis 1992; 14: 251–262
  • Pugliese A, Girardello R, Marinelli L, Forno B, Pattarino P L, Biglino A. Evaluation of Pidotimod effects on some immune parameters. J Chemother 1991; 3(Suppl 3)144–146
  • Illeni M T, Bombelli G, Pattarino P L, Poli A. NK cell cytotoxic activity induced by a synthetic immunostimulant (Pidotimod): an in vitro study. J Chemother 1991; 3(Suppl 3)157–159
  • Capsoni F, Minonzio F, Ongari A M, Girardello R, DiBello M, Zanussi C. In vitro and ex vivo enhancement of neutrophil function by PGT/1A, a new immunostimulating peptide. J Chemother 1991; 3(Suppl 3)147–149
  • Auteri A, Pasqui A L, Bruni F, Saletti M, Tafani M. PGT/1A, a new immunostimulating agent, is able to influence some aspects of immune response. Fifth International Conference on Immunopharmacology. May, 1991. Tampa, 26–30
  • Alwmark A, Bengmark S, Gullstrand P, Schalén C. Improvement of the splenectomized rat model for overwhelming pneumococcal infection. Eur Surg Res 1981; 13: 339–343

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.